↓ Skip to main content

Mechanisms of Relapse After CD19 CAR T-Cell Therapy for Acute Lymphoblastic Leukemia and Its Prevention and Treatment Strategies

Overview of attention for article published in Frontiers in immunology, November 2019
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (92nd percentile)
  • High Attention Score compared to outputs of the same age and source (95th percentile)

Mentioned by

twitter
33 X users
patent
2 patents

Citations

dimensions_citation
219 Dimensions

Readers on

mendeley
308 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Mechanisms of Relapse After CD19 CAR T-Cell Therapy for Acute Lymphoblastic Leukemia and Its Prevention and Treatment Strategies
Published in
Frontiers in immunology, November 2019
DOI 10.3389/fimmu.2019.02664
Pubmed ID
Authors

Xinjie Xu, Qihang Sun, Xiaoqian Liang, Zitong Chen, Xiaoli Zhang, Xuan Zhou, Meifang Li, Huilin Tu, Yu Liu, Sanfang Tu, Yuhua Li

X Demographics

X Demographics

The data shown below were collected from the profiles of 33 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 308 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 308 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 41 13%
Student > Ph. D. Student 35 11%
Student > Master 30 10%
Researcher 27 9%
Student > Doctoral Student 20 6%
Other 36 12%
Unknown 119 39%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 55 18%
Medicine and Dentistry 47 15%
Immunology and Microbiology 27 9%
Agricultural and Biological Sciences 17 6%
Pharmacology, Toxicology and Pharmaceutical Science 15 5%
Other 23 7%
Unknown 124 40%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 28. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 October 2023.
All research outputs
#1,411,282
of 25,806,080 outputs
Outputs from Frontiers in immunology
#1,234
of 32,415 outputs
Outputs of similar age
#29,751
of 376,480 outputs
Outputs of similar age from Frontiers in immunology
#25
of 604 outputs
Altmetric has tracked 25,806,080 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 32,415 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.4. This one has done particularly well, scoring higher than 96% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 376,480 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 92% of its contemporaries.
We're also able to compare this research output to 604 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 95% of its contemporaries.